Why the Lyme disease vaccine the US developed went off the market
Since 1998, confirmed Lyme disease cases in the US have risen roughly 40%. GlaxoSmithKline developed a Lyme vaccine in the 1990s. It went off the market by the early 2000s. A new anti-Lyme injection (not a vaccine) is coming. But it could take years to be fully approved. Loading Something is …
Read More